MY Qattan
Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia
Qattan, MY; Bakker, EY; Rajendran, R; Wei-Chen Chen, D; Saha, V; Liu, J; Schwartz, J; Mutti, L; Demonacos, C; Krstic- Demonacos, M
Authors
EY Bakker
R Rajendran
D Wei-Chen Chen
V Saha
J Liu
J Schwartz
L Mutti
C Demonacos
Prof Marija Krstic-Demonacos M.Krstic-Demonacos@salford.ac.uk
Professor
Abstract
Glucocorticoids (GCs) and topoisomerase II inhibitors are used to treat acute lymphoblastic leukaemia (ALL) as they induce death in lymphoid cells through the glucocorticoid receptor (GR) and p53 respectively. Mechanisms underlying ALL cell death and the contribution of the bone marrow microenvironment to drug response/resistance remain unclear. The role of the microenvironment and the identification of chemoresistance determinants were studied by transcriptomic analysis in ALL cells treated with Dexamethasone (Dex), and Etoposide (Etop) grown in the presence or absence of bone marrow conditioned media (CM). The necroptotic (RIPK1) and the apoptotic (caspase-8/3) markers were downregulated by CM, whereas the inhibitory effects of chemotherapy on the autophagy marker Beclin-1 (BECN1) were reduced suggesting CM exerts cytoprotective effects. GCs upregulated the RIPK1 ubiquitinating factor BIRC3 (cIAP2), in GC-sensitive (CEM-C7-14) but not in resistant (CEM-C1-15) cells. In addition, CM selectively affected GR phosphorylation in a site and cell-specific manner. GR is recruited to RIPK1, BECN1 and BIRC3 promoters in the sensitive but not in the resistant cells with phosphorylated GR forms being generally less recruited in the presence of hormone. FACS analysis and caspase-8 assays demonstrated that CM promoted a pro-survival trend. High molecular weight proteins reacting with the RIPK1 antibody were modified upon incubation with the BIRC3 inhibitor AT406 in CEM-C7-14 cells suggesting that they represent ubiquitinated forms of RIPK1. Our data suggest that there is a correlation between microenvironment-induced ALL proliferation and altered response to chemotherapy.
Journal Article Type | Article |
---|---|
Acceptance Date | May 26, 2017 |
Online Publication Date | Jun 5, 2017 |
Publication Date | Jun 5, 2017 |
Deposit Date | May 31, 2017 |
Publicly Available Date | Jul 11, 2017 |
Journal | PLoS ONE |
Electronic ISSN | 1932-6203 |
Publisher | Public Library of Science |
Volume | 12 |
Issue | 6 |
Pages | e0178606 |
DOI | https://doi.org/10.1371/journal.pone.0178606 |
Publisher URL | http://dx.doi.org/10.1371/journal.pone.0178606 |
Related Public URLs | http://journals.plos.org/plosone/ |
Files
file.pdf
(5.5 Mb)
PDF
Licence
http://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
You might also like
Investigation of P53 and TTC5 function in lung cancer
(2024)
Thesis
Targeting Transcriptional CDKs in Medulloblastoma
(2024)
Thesis
Evaluation of Novel Diketones as Anti-cancer Agents
(2024)
Thesis
Intratumor microbiota as a novel potential prognostic indicator in mesothelioma
(2023)
Journal Article
Elimination of Off-Target Effect by Chemical Modification of 5'-End of Small Interfering RNA
(2022)
Journal Article